Oragenics, Inc. Announces Concussion Drug Successfully Completes FDA-Required Genotoxicity Study – ONP-002 showed no cancer-causing DNA damage – Phase II clinical trial being planned SARASOTA, Fla., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on...

In Vivo Toxicology Market to Cross USD 9.5 Bn Revenue by 2033 | TMR Study Wilmington, Delaware, United States, April 11, 2023 (GLOBE NEWSWIRE) -- According to market research by TMR, the global in vivo toxicology industry is expected to witness significant growth during...

In-Vitro Toxicology/Toxicity Testing Market Worth $14.4 Billion by 2025, Growing at a CAGR of 9% from 2019- Global Opportunity Analysis and Industry Forecasts by Meticulous Research® London, June 23, 2020 (GLOBE NEWSWIRE) -- Safety assessment of substances is essential to determine their toxic implications on humans and the environment. Toxicology studies evaluate the substances...